Recommended concentration: FC: ≤ 0.25 μg per 10^6 cells in a volume of 100 μl.
Images
Agonist Cooperation of drozitumab and DOX in apoptosis induction of resistant cells in vitro. B. MDA-MB-231-TXSA-droz-R cells were treated as above and caspase-3-like activity was determined.
Depletes DR5+ cells Drozitumab treatment depletes DR5+ cells in vitro.
Agonist Cooperation of drozitumab and DOX in apoptosis induction of resistant cells in vitro. B. MDA-MB-231-TXSA-droz-R cells were treated as above and caspase-3-like activity was determined.
Depletes DR5+ cells Drozitumab treatment depletes DR5+ cells in vitro.
My Review for Anti-Human DR5 (Drozitumab) monoclonal antibody, Functional Grade
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Certificate of Analysis
